跳至主要内容
临床试验/NCT01697098
NCT01697098
已完成
2 期

Dexamethasone Dosing Interval: 12 or 24 Hours Apart? A Randomized,Clinical Trial

Assiut University1 个研究点 分布在 1 个国家目标入组 200 人2012年1月

概览

阶段
2 期
干预措施
Dexamethasone 12
疾病 / 适应症
Prematurity
发起方
Assiut University
入组人数
200
试验地点
1
主要终点
respiratory distress syndrome (RDS)
状态
已完成
最后更新
13年前

概览

简要总结

The investigators sought to determine whether the incidence of neonatal respiratory distress syndrome (RDS) in preterm fetuses is similar with 12- vs 24-hour dosing interval of dexamethasone.

详细描述

The administration of glucocorticoids to accelerate fetal lung maturity in patients with preterm delivery plays an important role for obstetrics and neonatal care. Many studies have shown that maternal administration of glucocorticoids has a significant beneficial effect in decreasing the incidence of respiratory distress syndrome (RDS) in infants delivered at 28-34 weeks of gestation.

注册库
clinicaltrials.gov
开始日期
2012年1月
结束日期
2012年8月
最后更新
13年前
研究类型
Interventional
研究设计
Parallel
性别
Female

研究者

责任方
Principal Investigator
主要研究者

Mohammed Khairy Ali

Women Health Hospital

Assiut University

入排标准

入选标准

  • All patient with threatened or established preterm labor between 28 - 34 weeks attended to our emergency unit

排除标准

  • emergent obstetric conditions like:
  • Antepartum hemorrhage in severe attack
  • Antepartum eclampsia

研究组 & 干预措施

12 hours Dexamethasone

Those patient will be given 12 hours dexamethasone after randomization

干预措施: Dexamethasone 12

24 hours Dexamethasone

Those patient will be give 24 hours dexamethasone after randomization

干预措施: Dexamethasone 24 hours

结局指标

主要结局

respiratory distress syndrome (RDS)

时间窗: 6 month

determine whether the incidence of neonatal respiratory distress syndrome (RDS) is similar with 12- vs 24-hour dosing interval of dexamethasone.

次要结局

  • Perinatal mortality(6 month)

研究点 (1)

Loading locations...

相似试验